- Report
- March 2025
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 266 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- February 2025
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2025
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2023
- 175 Pages
Global
From €5369EUR$5,899USD£4,603GBP
- Report
- March 2025
- 200 Pages
India
From €2266EUR$2,490USD£1,943GBP
- Report
- November 2023
- 135 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Book
- July 2015
- 384 Pages
Ciprofloxacin is an antibiotic used to treat a variety of bacterial infections, including those of the respiratory system. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Ciprofloxacin is used to treat bacterial pneumonia, bronchitis, sinusitis, and other respiratory infections. It is also used to treat infections of the skin, urinary tract, and gastrointestinal tract. Ciprofloxacin is available in both oral and intravenous forms.
Ciprofloxacin is a widely used antibiotic in the treatment of respiratory infections. It is generally well tolerated and has a low risk of side effects. It is also relatively inexpensive, making it a cost-effective treatment option.
Several companies manufacture and market ciprofloxacin, including Bayer, Pfizer, Merck, and GlaxoSmithKline. Generic versions of the drug are also available from a number of manufacturers. Show Less Read more
